Chemotherapy doctors in Turkey routinely work within multidisciplinary tumor boards to manage pancreatic cancer effectively. These boards include medical oncologists, surgeons, and radiologists who collaborate to review diagnostic data. This team-based approach determines the exact sequence of chemotherapy and surgical intervention for every patient.
- Specialized councils: Leading centers host disease-specific boards focusing exclusively on gastrointestinal and pancreatic oncology.
- Global standards: Turkish tumor boards align protocols with ESMO and ASCO guidelines for international consistency.
- Case reviews: Specialists collectively analyze imaging to decide if tumors are operable or require neoadjuvant chemotherapy.
- Comprehensive planning: Decisions involve pathologists and radiation oncologists to ensure all treatment modalities are integrated.
Bookimed Expert Insight: Data shows that top Turkish oncologists often hold dual certifications or international board memberships. For instance, Dr. Yesim Yildirim and Dr. Nail Paksoy are ESMO-certified, while Dr. Seref Komurcu is ECFMG-qualified. This international alignment ensures that tumor board discussions in clinics like Anadolu Medical Center or Medipol reflect the same clinical rigor found in leading US or European academic hospitals.
Patient Consensus: Patients note they feel much more confident when a full team reviews their case instead of just one doctor. They emphasize that seeing several specialists collaborate on imaging results helps clarify whether surgery is a viable option. Many were surprised by how quickly these multi-specialist consultations are organized compared to their home countries.
